Dudediligence.

Sagimet Biosciences Inc

SGMTNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$14.6MSep ’24−$16.2MDec ’24−$18.2MMar ’25−$10.4MJun ’25−$12.9MSep ’25−$9.6MDec ’25−$10.7MMar ’26−$14.0MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenuenone on filenone on file$2.0Mnone on filenone on file
Operating incomenone on file−$31.1M−$30.7M−$54.5M−$56.9M
Net incomenone on file−$30.5M−$27.9M−$45.6M−$51.0M
Operating cash flownone on file−$24.5M−$23.8M−$42.4M−$45.6M
Cash$56.7M$158,000$75.1M$75.8M$35.0M
Shares outstandingnone on file185.1K031.4M32.3M